vs
Side-by-side financial comparison of FutureFuel Corp. (FF) and EVERSPIN TECHNOLOGIES INC. (MRAM). Click either name above to swap in a different company.
FutureFuel Corp. is the larger business by last-quarter revenue ($19.8M vs $14.9M, roughly 1.3× EVERSPIN TECHNOLOGIES INC.). EVERSPIN TECHNOLOGIES INC. runs the higher net margin — -2.0% vs -60.5%, a 58.5% gap on every dollar of revenue. On growth, EVERSPIN TECHNOLOGIES INC. posted the faster year-over-year revenue change (13.2% vs -67.7%). Over the past eight quarters, EVERSPIN TECHNOLOGIES INC.'s revenue compounded faster (18.2% CAGR vs -41.7%).
FutureFuel Corporation is a developer and producer of chemicals and biofuels. It is listed on the New York Stock Exchange, with symbol FF.
Everspin Technologies, Inc. is a publicly traded semiconductor company headquartered in Chandler, Arizona, United States. It develops and manufactures discrete magnetoresistive RAM or magnetoresistive random-access memory (MRAM) products, including Toggle MRAM and Spin-Transfer Torque MRAM (STT-MRAM) product families. It also licenses its technology for use in embedded MRAM (eMRAM) applications, magnetic sensor applications as well as performs backend foundry services for eMRAM.
FF vs MRAM — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $19.8M | $14.9M |
| Net Profit | $-12.0M | $-296.0K |
| Gross Margin | -46.7% | 52.7% |
| Operating Margin | -62.9% | 29.0% |
| Net Margin | -60.5% | -2.0% |
| Revenue YoY | -67.7% | 13.2% |
| Net Profit YoY | -529.4% | — |
| EPS (diluted) | $-0.28 | $-0.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $14.9M | ||
| Q4 25 | $19.8M | $14.8M | ||
| Q3 25 | $22.7M | $14.1M | ||
| Q2 25 | $35.7M | $13.2M | ||
| Q1 25 | $17.5M | $13.1M | ||
| Q4 24 | $61.5M | $13.2M | ||
| Q3 24 | $51.1M | $12.1M | ||
| Q2 24 | $72.4M | $10.6M |
| Q1 26 | — | $-296.0K | ||
| Q4 25 | $-12.0M | $1.2M | ||
| Q3 25 | $-9.3M | $54.0K | ||
| Q2 25 | $-10.4M | $-670.0K | ||
| Q1 25 | $-17.6M | $-1.2M | ||
| Q4 24 | $2.8M | $1.2M | ||
| Q3 24 | $-1.2M | $2.3M | ||
| Q2 24 | $9.6M | $-2.5M |
| Q1 26 | — | 52.7% | ||
| Q4 25 | -46.7% | 50.8% | ||
| Q3 25 | -30.1% | 51.3% | ||
| Q2 25 | -24.6% | 51.3% | ||
| Q1 25 | -83.0% | 51.4% | ||
| Q4 24 | 9.1% | 51.3% | ||
| Q3 24 | 0.7% | 49.2% | ||
| Q2 24 | 12.0% | 49.0% |
| Q1 26 | — | 29.0% | ||
| Q4 25 | -62.9% | -7.2% | ||
| Q3 25 | -42.9% | -11.0% | ||
| Q2 25 | -33.4% | -14.9% | ||
| Q1 25 | -107.4% | -14.7% | ||
| Q4 24 | 2.6% | -11.8% | ||
| Q3 24 | -5.6% | -17.5% | ||
| Q2 24 | 7.5% | -26.5% |
| Q1 26 | — | -2.0% | ||
| Q4 25 | -60.5% | 8.1% | ||
| Q3 25 | -41.1% | 0.4% | ||
| Q2 25 | -29.2% | -5.1% | ||
| Q1 25 | -100.6% | -8.9% | ||
| Q4 24 | 4.5% | 9.2% | ||
| Q3 24 | -2.3% | 18.8% | ||
| Q2 24 | 13.2% | -23.5% |
| Q1 26 | — | $-0.01 | ||
| Q4 25 | $-0.28 | $0.05 | ||
| Q3 25 | $-0.21 | $0.00 | ||
| Q2 25 | $-0.24 | $-0.03 | ||
| Q1 25 | $-0.40 | $-0.05 | ||
| Q4 24 | $0.06 | $0.07 | ||
| Q3 24 | $-0.03 | $0.10 | ||
| Q2 24 | $0.22 | $-0.12 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $51.3M | $40.5M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $154.7M | $70.2M |
| Total Assets | $192.2M | $83.2M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $40.5M | ||
| Q4 25 | $51.3M | $44.5M | ||
| Q3 25 | $85.6M | $45.3M | ||
| Q2 25 | $95.2M | $45.0M | ||
| Q1 25 | $97.1M | $42.2M | ||
| Q4 24 | $109.5M | $42.1M | ||
| Q3 24 | $133.4M | $39.6M | ||
| Q2 24 | $115.1M | $36.8M |
| Q1 26 | — | $70.2M | ||
| Q4 25 | $154.7M | $68.9M | ||
| Q3 25 | $169.1M | $65.8M | ||
| Q2 25 | $178.2M | $64.1M | ||
| Q1 25 | $188.4M | $63.0M | ||
| Q4 24 | $205.8M | $62.6M | ||
| Q3 24 | $213.3M | $59.3M | ||
| Q2 24 | $214.4M | $55.4M |
| Q1 26 | — | $83.2M | ||
| Q4 25 | $192.2M | $84.6M | ||
| Q3 25 | $203.5M | $80.3M | ||
| Q2 25 | $218.2M | $78.9M | ||
| Q1 25 | $227.7M | $80.2M | ||
| Q4 24 | $247.7M | $77.8M | ||
| Q3 24 | $256.5M | $72.6M | ||
| Q2 24 | $261.2M | $64.6M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-27.4M | $570.0K |
| Free Cash FlowOCF − Capex | $-29.9M | — |
| FCF MarginFCF / Revenue | -150.5% | — |
| Capex IntensityCapex / Revenue | 12.2% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-46.0M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $570.0K | ||
| Q4 25 | $-27.4M | $2.6M | ||
| Q3 25 | $-1.1M | $881.0K | ||
| Q2 25 | $5.2M | $5.0M | ||
| Q1 25 | $-5.4M | $1.4M | ||
| Q4 24 | $-16.6M | $3.8M | ||
| Q3 24 | $25.8M | $2.8M | ||
| Q2 24 | $27.8M | $1.7M |
| Q1 26 | — | — | ||
| Q4 25 | $-29.9M | $-975.0K | ||
| Q3 25 | $-6.5M | $543.0K | ||
| Q2 25 | $-263.0K | $3.0M | ||
| Q1 25 | $-9.4M | $527.0K | ||
| Q4 24 | $-20.7M | $2.1M | ||
| Q3 24 | $20.5M | $2.8M | ||
| Q2 24 | $24.8M | $1.7M |
| Q1 26 | — | — | ||
| Q4 25 | -150.5% | -6.6% | ||
| Q3 25 | -28.5% | 3.9% | ||
| Q2 25 | -0.7% | 22.9% | ||
| Q1 25 | -53.6% | 4.0% | ||
| Q4 24 | -33.6% | 15.8% | ||
| Q3 24 | 40.1% | 22.9% | ||
| Q2 24 | 34.3% | 15.9% |
| Q1 26 | — | — | ||
| Q4 25 | 12.2% | 24.3% | ||
| Q3 25 | 23.5% | 2.4% | ||
| Q2 25 | 15.3% | 15.1% | ||
| Q1 25 | 22.8% | 6.9% | ||
| Q4 24 | 6.6% | 13.2% | ||
| Q3 24 | 10.4% | 0.5% | ||
| Q2 24 | 4.1% | 0.3% |
| Q1 26 | — | — | ||
| Q4 25 | — | 2.19× | ||
| Q3 25 | — | 16.31× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | -5.94× | 3.16× | ||
| Q3 24 | — | 1.25× | ||
| Q2 24 | 2.90× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FF
| Chemicals | $18.0M | 91% |
| Biofuels | $1.8M | 9% |
MRAM
| Product sales | $14.1M | 95% |
| Licensing, royalty, patent, engineering services and other revenue | $772.0K | 5% |
